Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
DIABETIC PATIENTS TAKING GLP-1S MAY FACE INCREASED RISK OF EYE DISEASE, STUDY SUGGESTS While individuals with type 2 diabetes on GLP-1s showed a modestly increased risk of diabetic retinopathy, the researchers concluded that fewer patients experienced sight-threatening complications from the disease
Studies show a possible link between semaglutide and NAION, a rare condition that can cause sudden vision loss
The convenience of oral tablets may matter to patients who sometimes avoid injectables out of aversion to needles
It's worth noting that increased heart rate is a recognised class effect of GLP-1 receptor agonists, which some individuals may perceive as anxiety or palpitations
Most Medicare beneficiaries would pay approximately $50/month out of pocket
US$ 22.46
US$ 20.31
US$ 26.56
US$ 28.48
US$ 26.44
US$ 23.27
US$ 26.85
US$ 26.50
